These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2332245

  • 1. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
    Heizmann WR, Heilmann F, Egeler B, Werner H.
    Infection; 1990; 18(2):117-21. PubMed ID: 2332245
    [Abstract] [Full Text] [Related]

  • 2. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
    Heizmann WR, Schmid R, Heilmann F, Werner H.
    Infection; 1989; 17(3):160-4. PubMed ID: 2737759
    [Abstract] [Full Text] [Related]

  • 3. Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus.
    Heilmann F.
    Infection; 1993; 21(3):187-90. PubMed ID: 8365818
    [Abstract] [Full Text] [Related]

  • 4. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR, Heilmann F, Werner H.
    Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD, Nightingale CH, Nicolau DP, Belliveau PP, Tessier PR, Fu Q, Xuan DW, Quintiliani R.
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV, Botta GA, Pesce A, Schito GC.
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H, Heizmann W, Heilmann F.
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.